The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
In Vitro Cellular Drug Resistance and Prognosis in Newly Diagnosed Childhood Acute Lymphoblastic Leukemia
Open accessAbstract
As an important determinant of the response to chemotherapy, measurements of cellular drug resistance may provide prognostically significant information, which could be useful for optimal risk-group stratification. The objective of this report is to determine the relation between in vitro resistance to 12 drugs, measured with the colorimetric methyl-thiazol-tetrazolium (MTT) assay, and long-term clinical response to chemotherapy in 152 children with newly diagnosed acute lymphoblastic leukemia. At risk-group stratified analyses, in vitro resistance to prednisolone, L-asparaginase, and vincristine were each significantly (P < .01) related to the probability of disease-free survival (pDFS) after combination chemotherapy. The combination of data for prednisolone, L-asparaginase, and vincristine provided a drug-resistance profile with prognostic independent significance superior to that of any single drug or any other factor. The 3-years pDFS was 100% for the group with the most sensitive profile, 20% of all patients, 84% (SE 6%) for the group with an intermediately sensitive profile, 40% of all patients, and 43% (SE 8%) for the remaining group with the most resistant profile (P < .001). In conclusion, the extent of in vitro cellular resistance to prednisolone, L-asparaginase, and vincristine, measured using the MTT assay, was significantly related to the clinical response to combination chemotherapy. Treatment failure in newly diagnosed childhood ALL can be predicted based on cellular drug resistance data.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Appraisal of the MTT assay as a rapid test of chemosensitivity in acute myeloid leukaemia
Sargent, J., & Taylor, C. (1989) · British Journal of Cancer · doi:10.1038/bjc.1989.252 · Cited by 285
Larsson, R., Kristensen, J., Sandberg, C., & Nygren, P. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910500204 · Cited by 245
Pieters, R., Loonen, A., Huismans, D., Broekema, G., Dirven, M., Heyenbrok, M., Hahlen, K., & Veerman, A. (1990) · Blood · doi:10.1182/blood.v76.11.2327.2327 · Cited by 232
Self-citationIn vitro cellular drug resistance in children with relapsed/refractory acute lymphoblastic leukemia
Klumper, E., Pieters, R., Veerman, A., Huismans, D., Loonen, A., Hahlen, K., Kaspers, G., van Wering, E., Hartmann, R., & Henze, G. (1995) · Blood · doi:10.1182/blood.v86.10.3861.bloodjournal86103861 · Cited by 217
Self-citationPieters, R., Huismans, D. R., Loonen, A. H., Veerman, A. J. P., Hahlen, K., van der Does-van den Berg, A., & Wering, E. R. (1991) · The Lancet · doi:10.1016/0140-6736(91)91029-t · Cited by 216
Self-citationPieters, R., Huismans, D. R., LEYVA, A., & Veerman, A. J. P. (1988) · Cancer Letters · doi:10.1016/0304-3835(88)90294-7 · Cited by 147
Self-citation
Cited by
Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., et al. (2006) · Science · doi:10.1126/science.1132939 · Cited by 5,257
Pui, C.-H., & Evans, W. E. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808273390907 · Cited by 832
Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia
Coustan-Smith, E., Sancho, J., Hancock, M. L., Boyett, J. M., Behm, F. G., Raimondi, S. C., Sandlund, J. T., Rivera, G. K., Rubnitz, J. E., Ribeiro, R. C., et al. (2000) · Blood · doi:10.1182/blood.v96.8.2691 · Cited by 484
Paugh, S. W., Bonten, E. J., Savic, D., Ramsey, L. B., Thierfelder, W. E., Gurung, P., Malireddi, R. K. S., Actis, M., Mayasundari, A., Min, J., et al. (2015) · Nature Genetics · doi:10.1038/ng.3283 · Cited by 164
Self-citationStams, W. A. G. (2003) · Blood · doi:10.1182/blood-2002-08-2446 · Cited by 149
Metadata
- Authors
- Kaspers, G. J. L., Veerman, A. J. P., Pieters, R., Van Zantwijk, C. H., Smets, L. A., Van Wering, E. R., & Van Der Does-Van Den Berg, A.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 1997-10-01
- Volume
- 90
- Issue
- 7
- Pages
- 2723-2729
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W1576233656
- Cited by
- 271
- References
- 21
- FWCI
- 17.56
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: In Vitro Cellular Drug Resistance and Prognosis in Newly Diagnosed Childhood Acute Lymphoblastic Leukemia. https://app.cochat.ai/papers/10.1182/blood.v90.7.2723
- The paper
- Kaspers, G. J. L., Veerman, A. J. P., Pieters, R., Van Zantwijk, C. H., Smets, L. A., Van Wering, E. R., & Van Der Does-Van Den Berg, A. (1997). In Vitro Cellular Drug Resistance and Prognosis in Newly Diagnosed Childhood Acute Lymphoblastic Leukemia. Blood. https://doi.org/10.1182/blood.v90.7.2723
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
